Pulmonary alveolar proteinosis in children

Jacques de Blic1

  • 1Service de Pneumologie et Allergologie Pédiatriques, Hôpital Necker Enfants Malades, 149 rue de Sèvres 75015, Paris, France. j.deblic@nck.ap-hop-paris.fr

Insights

Pulmonary alveolar proteinosis (PAP) is a rare pediatric lung disease. Bronchoalveolar lavage aids diagnosis, and while treatments exist, underlying mechanisms require further research.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Interstitial Lung Disease

Background:

  • Pulmonary alveolar proteinosis (PAP) is a rare condition in children.
  • It involves the buildup of lipoproteinaceous material in the alveoli.
  • This leads to chronic interstitial lung disease.

Purpose of the Study:

  • To summarize the key aspects of pediatric Pulmonary alveolar proteinosis.
  • To highlight diagnostic methods and current therapeutic limitations.
  • To underscore the need for further research into underlying mechanisms.

Main Methods:

  • Review of diagnostic criteria for PAP.
  • Analysis of clinical presentations and heterogeneity.
  • Summary of current treatment modalities and their effectiveness.

Main Results:

  • Bronchoalveolar lavage is crucial for diagnosis, showing milky fluid and PAS-positive material.
  • PAP presents heterogeneously, with immediate-onset forms linked to SP-B deficiency.
  • Postnatal-onset PAP can be primary or secondary, with variable progression.

Conclusions:

  • Understanding the heterogeneity of PAP is essential for management.
  • While therapeutic lung lavages are effective for severe cases, further research into GM-CSF pathways is needed.
  • Accurate diagnosis and understanding of underlying mechanisms are critical for improving outcomes in pediatric PAP.

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...